These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. A close-up on the epidemiology and transmission of multidrug-resistant tuberculosis in Poland. Jagielski T; Brzostek A; van Belkum A; Dziadek J; Augustynowicz-Kopeć E; Zwolska Z Eur J Clin Microbiol Infect Dis; 2015 Jan; 34(1):41-53. PubMed ID: 25037868 [TBL] [Abstract][Full Text] [Related]
10. Therapy of Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis. Seaworth BJ; Griffith DE Microbiol Spectr; 2017 Mar; 5(2):. PubMed ID: 28361737 [TBL] [Abstract][Full Text] [Related]
11. Management of multidrug resistant tuberculosis. Daley CL; Caminero JA Semin Respir Crit Care Med; 2013 Feb; 34(1):44-59. PubMed ID: 23460005 [TBL] [Abstract][Full Text] [Related]
12. An update on multidrug-resistant tuberculosis . Park M; Satta G; Kon OM Clin Med (Lond); 2019 Mar; 19(2):135-139. PubMed ID: 30872297 [TBL] [Abstract][Full Text] [Related]
13. The Potential Impact of Up-Front Drug Sensitivity Testing on India's Epidemic of Multi-Drug Resistant Tuberculosis. Sachdeva KS; Raizada N; Gupta RS; Nair SA; Denkinger C; Paramasivan CN; Kulsange S; Thakur R; Dewan P; Boehme C; Arinaminpathy N PLoS One; 2015; 10(7):e0131438. PubMed ID: 26132584 [TBL] [Abstract][Full Text] [Related]
14. Risk factors of multidrug-resistant tuberculosis: A global systematic review and meta-analysis. Pradipta IS; Forsman LD; Bruchfeld J; Hak E; Alffenaar JW J Infect; 2018 Dec; 77(6):469-478. PubMed ID: 30339803 [TBL] [Abstract][Full Text] [Related]
15. Editorial: Updates from the World Health Organization (WHO) on Global Treatment Recommendations for Drug-Susceptible and Multidrug-Resistant Tuberculosis. Parums DV Med Sci Monit; 2021 Aug; 27():e934292. PubMed ID: 34366429 [TBL] [Abstract][Full Text] [Related]
16. Comparison of the socio-demographic and clinical features of pulmonary TB patients infected with sub-lineages within the W-Beijing and non-Beijing Mycobacterium tuberculosis. Hu Y; Mathema B; Zhao Q; Zheng X; Li D; Jiang W; Wang W; Xu B Tuberculosis (Edinb); 2016 Mar; 97():18-25. PubMed ID: 26980491 [TBL] [Abstract][Full Text] [Related]
17. Epidemiology of Pediatric Multidrug-Resistant Tuberculosis in the United States, 1993-2014. Smith SE; Pratt R; Trieu L; Barry PM; Thai DT; Ahuja SD; Shah S Clin Infect Dis; 2017 Oct; 65(9):1437-1443. PubMed ID: 28633501 [TBL] [Abstract][Full Text] [Related]
18. Extensive global movement of multidrug-resistant Cohen KA; Manson AL; Abeel T; Desjardins CA; Chapman SB; Hoffner S; Birren BW; Earl AM Thorax; 2019 Sep; 74(9):882-889. PubMed ID: 31048508 [TBL] [Abstract][Full Text] [Related]
19. Global burden of latent multidrug-resistant tuberculosis: trends and estimates based on mathematical modelling. Knight GM; McQuaid CF; Dodd PJ; Houben RMGJ Lancet Infect Dis; 2019 Aug; 19(8):903-912. PubMed ID: 31281059 [TBL] [Abstract][Full Text] [Related]
20. Fighting the tuberculosis epidemic in the Western Pacific region: current situation and challenges ahead. van Maaren PJ Kekkaku; 2010 Jan; 85(1):9-16. PubMed ID: 20143671 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]